bms204352 has been researched along with hmr 1556 in 1 studies
| Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (hmr 1556) | Trials (hmr 1556) | Recent Studies (post-2010) (hmr 1556) |
|---|---|---|---|---|---|
| 49 | 1 | 12 | 48 | 0 | 13 |
| Protein | Taxonomy | bms204352 (IC50) | hmr 1556 (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily KQT member 1 | Cavia porcellus (domestic guinea pig) | 0.12 | |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | 0.12 | |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | 0.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
1 review(s) available for bms204352 and hmr 1556
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |